Related Experiment Video
Updated: Aug 11, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
G2 DNA damage checkpoint inhibition and antimitotic activity of 13-hydroxy-15-oxozoapatlin
N T Rundle1, L Xu, R J Andersen
1Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
Abstract:
Checkpoints activated in response to DNA damage cause arrest in the G(1) and G(2) phases of the cell cycle. Inhibitors of the G(2) checkpoint may be used as tools to study this response and also to increase the effectiveness of DNA-damaging therapies against cancers lacking p53 function. Using a cell-based assay for G(2) checkpoint inhibitors, we have screened extracts from the NCI National Institutes of Health Natural Products Repository and have identified 13-hydroxy-15-oxozoapatlin (OZ) from the African tree Parinari curatellifolia. Flow cytometry with a mitosis-specific antibody showed that checkpoint inhibition by OZ was maximal at 10 microm, which released 20% of irradiated MCF-7 cells expressing defective p53 and 30% of irradiated HCT116p53(-/-) cells from G(2) arrest. OZ additively increased the response to the checkpoint inhibitors isogranulatimide and debromohymenialdisine, but it did not augment the effects of UCN-01 or caffeine. Unlike other checkpoint inhibitors, OZ did not inhibit ataxia-telangiectasia mutated (ATM), ATM and Rad3-related (ATR), Chk1, Chk2, Plk1, or Ser/Thr protein phosphatases in vitro. Treatment with OZ also caused G(2)-arrested and cycling cells to arrest in mitosis in a state resembling prometaphase. In these cells, the chromosomes were condensed and scattered over disordered mitotic spindles. The results demonstrate that OZ is both a G(2) checkpoint inhibitor and an antimitotic agent.
Insights
13-hydroxy-15-oxozoapatlin (OZ), a compound from Parinari curatellifolia, inhibits the G(2) cell cycle checkpoint. It also acts as an antimitotic agent, arresting cells in mitosis, and shows potential in cancer therapy.
Area of Science:
- Cell Biology
- Molecular Biology
- Pharmacology
Background:
- DNA damage triggers cell cycle checkpoints, arresting cells in G(1) and G(2) phases.
- G(2) checkpoint inhibitors are valuable tools for studying DNA damage response and enhancing cancer therapies, especially in p53-deficient cancers.
Purpose of the Study:
- To screen for novel G(2) checkpoint inhibitors from natural products.
- To characterize the mechanism of action of identified compounds, specifically 13-hydroxy-15-oxozoapatlin (OZ).
Main Methods:
- Utilized a cell-based assay to screen extracts from the NCI Natural Products Repository.
- Employed flow cytometry with a mitosis-specific antibody to assess G(2) checkpoint inhibition.
- Performed in vitro assays to evaluate the inhibition of key cell cycle regulatory proteins (ATM, ATR, Chk1, Chk2, Plk1, phosphatases).
Main Results:
- Identified 13-hydroxy-15-oxozoapatlin (OZ) from *Parinari curatellifolia* as a G(2) checkpoint inhibitor.
- OZ maximally inhibited the G(2) checkpoint at 10 microm, releasing irradiated MCF-7 (p53-defective) and HCT116p53(-/-) cells from arrest.
- OZ exhibited additive effects with isogranulatimide and debromohymenialdisine but not UCN-01 or caffeine; it did not inhibit major kinases or phosphatases.
- OZ induced a prometaphase-like mitotic arrest with condensed, scattered chromosomes and disordered spindles.
Conclusions:
- OZ functions as a G(2) checkpoint inhibitor and an antimitotic agent.
- OZ's unique mechanism, distinct from known kinase/phosphatase inhibition, warrants further investigation for therapeutic applications in cancer.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Drugs that Stabilize Microtubules
The Intrinsic Apoptotic Pathway
Drugs that Destabilize Microtubules
DNA Damage Can Stall the Cell Cycle

